H.R. 4752In Committee
Reducing Hereditary Cancer Act
Introduced: Jul 23, 2025
Latest action date: Jul 23, 2025
Your view
Executive Summary
Reducing Hereditary Cancer Act
This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.
Latest Action
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Discussion
0 comments
No comments yet. Start the conversation.